Using the GEMM-ESC strategy to study gene function in mouse models

Nature Protocols

Volumn 10, Issue 11, 2015, Pages 1755-1785

  Huijbers, Ivo J ^a   Del Bravo, Jessica ^a   Bin Ali, Rahmen ^a   Pritchard, Colin ^a   Braumuller, Tanya M ^a   Van Miltenburg, Martine H ^a   Henneman, Linda ^a   Michalak, Ewa M ^a   Berns, Anton ^a,b   Jonkers, Jos ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CRISPR ASSOCIATED PROTEIN; RECOMBINASE; RNA; PROTEIN;

ARTICLE; CHIMERA; CULTURE MEDIUM; EMBRYONIC STEM CELL; EXPERIMENTAL MODEL; GENE FUNCTION; GENE INSERTION; GENETIC ANALYSIS; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETICALLY ENGINEERED MOUSE STRAIN; GENOTYPE; IN VIVO STUDY; INTERMETHOD COMPARISON; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGENY; RNA EDITING; TIME; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE EXPRESSION; GENE TARGETING; GENETIC RECOMBINATION; METABOLISM; PHYSIOLOGY; PROCEDURES;

ANIMALS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; EMBRYONIC STEM CELLS; GENE EXPRESSION; GENE TARGETING; MICE, TRANSGENIC; PROTEINS; RECOMBINATION, GENETIC; TRANSGENES;

EID: 84944407375     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2015.114     Document Type: Article

References (60)

1. Sato, T. & Clevers, H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340, 1190-1194 (2013).
2. Vidi, P.A., Bissell, M.J. & Lelievre, S.A. Three-dimensional culture of human breast epithelial cells: the how and the why. Methods Mol. Biol. 945, 193-219 (2013).
3. Sanchez Alvarado, A. & Yamanaka, S. Rethinking differentiation: stem cells, regeneration, and plasticity. Cell 157, 110-119 (2014).
4. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
5. Frese, K.K. & Tuveson, D.A. Maximizing mouse cancer models. Nat. Rev. Cancer 7, 645-658 (2007).
6. Dranoff, G. Experimental mouse tumour models: what can be learnt about human cancer immunology? Nat. Rev. Immunol. 12, 61-66 (2012).
7. Couzin-Frankel, J. Breakthrough of the year 2013. Cancer immunotherapy. Science 342, 1432-1433 (2013).
8. Camacho, L.H. CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations. Cancer Med. 4, 661-672 (2015).
9. Huijbers, I.J., Krimpenfort, P., Berns, A. & Jonkers, J. Rapid validation of cancer genes in chimeras derived from established genetically engineered mouse models. Bioessays 33, 701-710 (2011).
10. Henneman, L. et al. Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer. Proc. Natl. Acad. Sci. USA 112, 8409-8414 (2015).
11. Huijbers, I.J. et al. Rapid target gene validation in complex cancer mouse models using re-derived embryonic stem cells. EMBO Mol. Med. 6, 212-225 (2014).
12. Ivics, Z. et al. Germline transgenesis in rabbits by pronuclear microinjection of Sleeping Beauty transposons. Nat. Protoc. 9, 794-809 (2014).
13. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
14. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
15. Miller, J.C. et al. A TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29, 143-148 (2011).
16. Ran, F.A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281-2308 (2013).
17. Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S. & Gregory, P.D. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11, 636-646 (2010).
18. Zhang, F. et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 29, 149-153 (2011).
19. Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910-918 (2013).
20. Yang, H. et al. One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering. Cell 154, 1370-1379 (2013).
21. Silva, J. et al. Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 6, e253 (2008).
22. Ying, Q.L. et al. The ground state of embryonic stem cell self-renewal. Nature 453, 519-523 (2008).
23. Czechanski, A. et al. Derivation and characterization of mouse embryonic stem cells from permissive and nonpermissive strains. Nat. Protoc. 9, 559-574 (2014).
24. Hanna, J. et al. Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell 4, 513-524 (2009).
25. Nichols, J. et al. Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat. Med. 15, 814-818 (2009).
26. Reinholdt, L.G. et al. Generating embryonic stem cells from the inbred mouse strain DBA/2J, a model of glaucoma and other complex diseases. PLoS ONE 7, e50081 (2012).
27. Premsrirut, P.K. et al. A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell 145, 145-158 (2011).
28. Saborowski, M. et al. A modular and flexible ESC-based mouse model of pancreatic cancer. Genes Dev. 28, 85-97 (2014).
29. van Miltenburg, M.H. & Jonkers, J. Using genetically engineered mouse models to validate candidate cancer genes and test new therapeutic approaches. Curr. Opin. Genet. Dev. 22, 21-27 (2012).
30. Beard, C., Hochedlinger, K., Plath, K., Wutz, A. & Jaenisch, R. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis 44, 23-28 (2006).
31. Premsrirut, P.K., Dow, L.E., Park, Y., Hannon, G.J. & Lowe, S.W. Creating transgenic shRNA mice by recombinase-mediated cassette exchange. Cold Spring Harb. Protoc. 2013, 835-842 (2013).
32. Fu, Y. et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31, 822-826 (2013).
33. Hsu, P.D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827-832 (2013).
34. Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839-843 (2013).
35. Smith, C. et al. Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs. Cell Stem Cell 15, 12-13 (2014).
36. Veres, A. et al. Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing. Cell Stem Cell 15, 27-30 (2014).
37. Mali, P. et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31, 833-838 (2013).
38. Ran, F.A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380-1389 (2013).
39. Lloyd, K., Franklin, C., Lutz, C. & Magnuson, T. Reproducibility: use mouse biobanks or lose them. Nature 522, 151-153 (2015).
40. Dow, L.E. et al. Conditional reverse tet-transactivator mouse strains for the efficient induction of TRE-regulated transgenes in mice. PLoS ONE 9, e95236 (2014).
41. Dow, L.E. et al. A pipeline for the generation of shRNA transgenic mice. Nat. Protoc. 7, 374-393 (2012).
42. Kiyonari, H., Kaneko, M., Abe, S. & Aizawa, S. Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline-competent embryonic stem cells of C57BL/6N mouse strain with high efficiency and stability. Genesis 48, 317-327 (2010).
43. Tamm, C., Pijuan Galito, S. & Anneren, C. A comparative study of protocols for mouse embryonic stem cell culturing. PLoS ONE 8, e81156 (2013).
44. Liang, Q., Conte, N., Skarnes, W.C. & Bradley, A. Extensive genomic copy number variation in embryonic stem cells. Proc. Natl. Acad. Sci. USA 105, 17453-17456 (2008).
45. Pettitt, S.J. et al. Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat. Methods 6, 493-495 (2009).
46. Bin Ali, R. et al. Improved pregnancy and birth rates with routine application of nonsurgical embryo transfer. Transgenic Res. 23, 691-695 (2014).
47. te Riele, H., Maandag, E.R. & Berns, A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. USA 89, 5128-5132 (1992).
48. Heiman, M. et al. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135, 738-748 (2008).
49. Krimpenfort, P. et al. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448, 943-946 (2007).
50. Solter, D. & Knowles, B.B. Immunosurgery of mouse blastocyst. Proc. Natl. Acad. Sci. USA 72, 5099-5102 (1975).
51. McFarlane, L., Truong, V., Palmer, J.S. & Wilhelm, D. Novel PCR assay for determining the genetic sex of mice. Sex. Dev. 7, 207-211 (2013).
52. Hogan, B., Beddington, R., Costantini, F. & Lacy, E. Manipulating the mouse embryo. 2nd edn. (Cold Spring Harbor Laboratory Press, 1994).
53. Wong, K. et al. Sequencing and characterization of the FVB/NJ mouse genome. Genome Biol. 13, R72 (2012).
54. Yalcin, B., Adams, D.J., Flint, J. & Keane, T.M. Next-generation sequencing of experimental mouse strains. Mamm. Genome 23, 490-498 (2012).
55. Yalcin, B. et al. The fine-scale architecture of structural variants in 17 mouse genomes. Genome Biol. 13, R18 (2012).
56. Meuwissen, R. et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. Cancer Cell 4, 181-189 (2003).
57. Jackson, E.L. et al. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15, 3243-3248 (2001).
58. Jongsma, J. et al. A conditional mouse model for malignant mesothelioma. Cancer Cell 13, 261-271 (2008).
59. Liu, X. et al. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Proc. Natl. Acad. Sci. USA 104, 12111-12116 (2007).
60. Derksen, P.W. et al. Mammary-specific inactivation of E-cadherin and p53 impairs functional gland development and leads to pleomorphic invasive lobular carcinoma in mice. Dis. Model Mech. 4, 347-358 (2011).